We developed a model to cultivate MCF-7 cells under conditions of estrogen depletion, to mimic the process that occurs naturally with menopause, and the use of aromatase inhibitors as hormonal therapy in breast cancer. Here, CYP19A1 is linked to breast carcinoma.